ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

20.82
Delayed Data
As of Sep 29
 -0.71 / -3.30%
Today’s Change
13.73
Today|||52-Week Range
33.99
+30.78%
Year-to-Date
2 Growth Stocks I'd Buy on the Dip
Sep 30 / MotleyFool.com - Paid Partner Content
Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?
Sep 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close21.53
Today’s open21.45
Day’s range20.54 - 21.45
Volume197,465
Average volume (3 months)1,684,328
Market cap$3.4B
Data as of 4:00pm ET, 09/29/2023

Growth & Valuation

Earnings growth (last year)-27.71%
Earnings growth (this year)+76.75%
Earnings growth (next 5 years)-2.00%
Revenue growth (last year)+6.83%
P/E ratioNM
Price/Sales4.98
Price/Book8.43

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.29+2.45%
EVOEvotec SE+0.20+2.05%
----
KRYSKrystal Biotech Inc-1.80-1.53%
Data as of 4:00pm ET, 09/29/2023

Financials

Next reporting dateNovember 6, 2023
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$517.2M
Annual profit (last year)-$216.0M
Net profit margin-41.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Diego, California

Forecasts